| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Radiology, Stanford University School of Medicine, Stanford, California 94305 [G. M. H., S. R., R. F. K., L. F. G.], and Institut Gustave-Roussy, 16 bis, Avenue Paul-Vaillant-Couturier, 94 Villejuif (Val-de-Marne), [E. F.] France
The survival of cells from two transplantable murine tumors (NCTC 2472 fibrosarcoma and EMT6 mammary sarcoma), X-irradiated in vivo, was assayed by determining the clonogenicity of the cells in vitro. Cells from tumors kept in situ 6 or 24 hr after irradiation had higher survival than cells from tumors excised immediately after irradiation. This increase in survival was done dependent and had a time constant of 2 to 4 hr. Similarity to earlier in vitro findings leads us to interpret the enhanced survival as a manifestation of repair of potentially lethal damage by cells remaining in a growth-inhibited state after irradiation.
1 This work was supported by INSERM (France) and by USPHS Grants CA-10372 and CA-04542.
2 Holder of a Dernham Senior Fellowship in Oncology from the American Cancer Society (California Division).
Received 6/20/73. Accepted 11/ 9/73.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |